101 March 11, 2026 On February 20, 2026, the U.S. Court of Appeals for the Federal Circuit (CAFC) issued a decision regarding recombinant DNA subject-matter eligibility, reversing a decision by the ...
101 Author: David Inglefield March 11, 2026 On February 20, 2026, the U.S. Court of Appeals for the Federal Circuit (CAFC) issued a decision regarding recombinant DNA subject-matter eligibility, ...
How you Do It May Lead to Invalidity under Section 101 October 5, 2022 Integrated Technology Solutions, LLC (“ITS”) alleged that products manufactured and distributed by iRacing.com Motorsport ...
Communications Channel Are Patent Ineligible under Section 101 August 23, 2021 Plaintiff Zyrcuits IP LLC has sued Defendants Acuity Brands, Inc. and Universal Electronics Inc. for infringement of claim ...
PTAB Reverses §101 and §103 Rejections for Plant Extract December 13, 2022 Update by Grace Kim and Sara Pistilli, PharmD. On December 6, 2022, the Patent Trial and Appeal Board (PTAB) overturned ...
and Patent Eligibility Under Section 101 March 30, 2020 Before LOURIE, MOORE, and REYNA, Circuit Judges. Illumina, Inc. and Sequenom, Inc. (“Illumina”) filed suit against Ariosa Diagnostics, Inc....
101 September 13, 2019 On August 27, 2019, in INO Therapeutics LLC v. Praxair Distribution Inc., in a 2-1 decision, the Federal Circuit upheld a district court decision that method-of-treatment claims,...
Patent Eligibility Under 35 U.S.C. 101 of Articles of Manufacture November 6, 2019 FYF-JB, LLC sued Pet Factory, Inc. for infringing its U.S. Patent 9,681,643 (“the ‘643 patent”) covering a tug ...
Four Decisions Designated Informative on 101: Positive Trend for Life Sciences? July 2, 2019 In January, 2019, the USPTO issued new guidance about what constitutes an abstract idea that is ineligible ...
During Prosecution Has Important Implications for 101 Challenges September 19, 2019 Five years after Alice Corp. Pty. v. CLS Bank Int'l, 573 U.S. 208 (2014) and the institution of the Alice test, district ...